Member Info for RorkesDrift

BBI have this on their website.

They also describe the need for user ability trusting as part of the regulatory framework. It is actually a well known requirement for tests performed by the individual rather than HCP. Clinical validation is a different requirement.

They also have their own smart app

https://bbisolutions.com/about-us/events/webinar-how-are-mobile-medical-apps-regulated.html

Bump

DONE

Um, er, neutralising therapy?

https://www.europeanpharmaceuticalreview.com/news/125266/interleukin-6-inhibitors-improve-outcomes-for-covid-19-patients-in-study/

Now if only there was a version that would get directly where needed in High doses and greater tolerability.

https://www.niaid.nih.gov/news-events/nih-clinical-trial-testing-remdesivir-plus-interferon-beta-1a-covid-19-treatment-begins

I completely get what you are saying but for every doubter there seems to be more than enough happy clappers. You know from my postings how long I have been here and as you say we are each responsible for our own research. There is a hardcore here and on the whole incredibly generous with their time and links to really important stuff. The whole really is better than the sum of the parts. I've made money following the facts presented on here - we know who those guys are cause we click on the links or follow up with independent verification. They tend to be to the point and use one word not paragraphs although ill let Myles off (again lot of work and evidence).

Other than that opinions are what they are - mildly interesting, often amusing but if we are to avoid being an echo chamber they are all important. Hats off to global - he takes a lot of abuse on here but I have a feeling every time he gets a rise he is laughing his head off. Every time it gets personnel all you do is create an opportunity for someone who really doesn't care to wind you up. If you don't agree with them then challenge the argument.

Apologies I'm p******d.

Guy from Manchester explained it brilliantly. We is going to be fine.

I hope ;-)

Apologies if posted before - interferon made simple enough for me and supports earlier rather than later use.

I declare I have a position in Swedish Orphan who make an IL1 receptor antagonists for patients who have gone too far

https://www.freethink.com/articles/coronavirus-immune-response

Given the Donald was so enthusiastic about malaria drug you think he would start banging on about Syn now

Think it contagious "Synairgen shares have enjoyed similar massive success to Novacyt. Unlike Novacyt, they are currently not far off a high of GBX 51, but have slipped in recent days to trade at GBX 38."

My misteak. I'd been reading another trial and got mixed up.

A course is made up of a number of doses?

Was the AZ thing because they just raised £3B. Big leap to say its for an acquisition let alone NYCT. The RNS doesn't suggest it - hell we would be a better buy than that as would synairgen or Swedish orphan given they area pharma company.

Ooops....

Given they are doing a home arm of study as well that implies potential pool of patients could be much bigger.

More and more is coming out about "long covid" and the cost of this. They will want to identify risk factors rather than treat everyone prophylacticly I think (IMHO). If we say 10% of non hospitalised patients too then we are going to need a bigger boat.

There again we havent seen the at home data so chickens counting ....

Jeez it gets worse. Risk weighting not waiting.

There again....

Thanks all. We can all await our recruitment calls from Finncapp.

The risk waiting is fine if buying mutiple risks. We are not so it will either be a lot more or a lot less. Additionally given the statistical analysis is already available 50% chance would seem way off.
However, the consensus has spoken - exciting times but I've no finger nails left.

One day purple lackey is going to post something useful. The answer is yes if you are a taker.

I've never owed so many shares in a company before. I'm hoping it goes up a penny.

1300 x 750 I mean